| 000 | 01728 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517082907.0 | ||
| 264 | 0 | _c20160909 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/STROKEAHA.116.012684 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPurrucker, Jan C | |
| 245 | 0 | 0 |
_aSafety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. _h[electronic resource] |
| 260 |
_bStroke _cApr 2016 |
||
| 300 |
_a1127-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aEndovascular Procedures _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracranial Hemorrhages _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aStroke _xdrug therapy |
| 650 | 0 | 4 |
_aThrombectomy _xadverse effects |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWolf, Marcel | |
| 700 | 1 | _aHaas, Kirsten | |
| 700 | 1 | _aRizos, Timolaos | |
| 700 | 1 | _aKhan, Shujah | |
| 700 | 1 | _aDziewas, Rainer | |
| 700 | 1 | _aKleinschnitz, Christoph | |
| 700 | 1 | _aBinder, Andreas | |
| 700 | 1 | _aGröschel, Klaus | |
| 700 | 1 | _aHennerici, Michael G | |
| 700 | 1 | _aLobotesis, Kyriakos | |
| 700 | 1 | _aPoli, Sven | |
| 700 | 1 | _aSeidel, Günter | |
| 700 | 1 | _aNeumann-Haefelin, Tobias | |
| 700 | 1 | _aRingleb, Peter A | |
| 700 | 1 | _aHeuschmann, Peter U | |
| 700 | 1 | _aVeltkamp, Roland | |
| 773 | 0 |
_tStroke _gvol. 47 _gno. 4 _gp. 1127-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/STROKEAHA.116.012684 _zAvailable from publisher's website |
| 999 |
_c25784909 _d25784909 |
||